LOS ANGELES, May 03, 2018 -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the May 4, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Grupo Televisa, S.A.B. (“Televisa” or the “Company”) (NYSE:TV) securities between April 11, 2013 and January 25, 2018, inclusive (the “Class Period”).
To obtain information or actively participate in the class action, please visit the Televisa page on our website at www.glancylaw.com/case/grupo-televisa-sab.
Investors suffering losses on their Televisa investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to [email protected].
On November 14, 2017, Reuters reported that a prosecution witness in the trial of three former soccer officials testified that Televisa paid bribes to secure television rights for soccer matches. On this news, Televisa’s ADR price fell $0.48, or 2.4%, to close at $19.50 on November 14, 2017, thereby injuring investors.
The Complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants failed to disclose that: (i) Televisa executives engaged in an unlawful bribery scheme involving Fédération Internationale de Football Association (“FIFA”) executives; (ii) discovery of the foregoing conduct would likely subject the Company to heightened regulatory scrutiny; (iii) the Company lacked effective internal controls over financial reporting; and (iv) as a result of the foregoing, Televisa’s ADRs traded at artificially inflated prices during the Class Period, and class members suffered significant losses and damages.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of Televisa during the Class Period you may move the Court no later than May 4, 2018 to ask the Court to appoint you as lead. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
Glancy Prongay and Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
www.glancylaw.com
[email protected]


BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Japan Regional Bank Stocks Drop After Zentoshin Bankruptcy Sparks Credit Risk Concerns
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand
OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
Lockheed Martin, Rheinmetall Plan First ATACMS Missile Production in Germany
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 



